Insider · CIK 0001822933
Anula Jayasuriya
Files at LCTX (Lineage Cell Therapeutics, Inc.), JAGX (Jaguar Health, Inc.). First filing -, latest -.
In brief
Anula Jayasuriya files SEC Form 4 as director at LCTX (Lineage Cell Therapeutics, Inc.), and also at JAGX (Jaguar Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Anula Jayasuriya has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jul 2, 2026 |
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Common Stock | +5,870 | $0.00 | $0 | 5,916 | Dec 15, 2025 |
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,870 | $0.00 | $0 | 5,870 | Dec 15, 2025 |
| Jul 1, 2025 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jul 2, 2025 |
Questions about Anula Jayasuriya
Answered from the filings on this page, as of the latest one.
Is Anula Jayasuriya buying or selling?
Anula Jayasuriya has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Anula Jayasuriya's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anula Jayasuriya has 0.
Where does Anula Jayasuriya file Form 4?
Anula Jayasuriya has filed Form 4 at LCTX (Lineage Cell Therapeutics, Inc.); JAGX (Jaguar Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.